论文部分内容阅读
目的探讨临床慢性肺源性心脏病心力衰竭患者的治疗方法,从而总结分析治疗体会。方法选取我院自2014年6月至2015年6月收治的150例慢性肺源性心脏病心力衰竭患者进行分析研究,将150例病患随机分为两组,每组各75例,对照组的病患进行常规治疗,研究组的病患在常规治疗基础上在进行综合治疗,分析两组的治疗效果。结果研究组的总有效率为93.3%(70/75);对照组的总有效率为81.3%(61/75),对比两组结果 P<0.05具有统计学意义。在治疗中发现,研究组总不良反应发生率仅为6.7%(5/75);对照组总不良反应发生率为14.7%(11/75),结果对比P<0.05,具有统计学意义。结论对进行慢性肺源性心脏病心力衰竭患者采用综合治疗,可有效改善患者临床病症,帮助患者减轻痛苦,提高患者的生活质量,临床不良反应率低,是安全、可靠、有效的治疗方式,值得临床广泛推广应用。
Objective To investigate the clinical treatment of patients with chronic cor pulmonale heart failure, and to summarize and analyze the treatment experience. Methods 150 cases of patients with chronic cor pulmonale heart failure who were treated in our hospital from June 2014 to June 2015 were selected and analyzed. 150 patients were randomly divided into two groups, 75 cases in each group. The control group Of patients with conventional treatment, the study group of patients in the conventional treatment based on the comprehensive treatment, analysis of the two groups of treatment. Results The total effective rate of the study group was 93.3% (70/75). The total effective rate of the control group was 81.3% (61/75). P <0.05 was statistically significant compared with the two groups. The treatment group found that the incidence of adverse reactions in the study group was only 6.7% (5/75). The incidence of adverse reactions in the control group was 14.7% (11/75). The results were statistically significant compared with P <0.05. Conclusions The comprehensive treatment of patients with heart failure of chronic cor pulmonale can effectively improve clinical symptoms, help patients to relieve the pain, improve the quality of life of patients, and have a low rate of adverse clinical reactions. It is a safe, reliable and effective treatment, It is worth widely clinical application.